mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
EHT 1864 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.3 |
0.04 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |